The European Medicines Agency has started a review of medicines containing finasteride and dutasteride following concerns ...

Patients received ER alfuzosin 5 mg twice daily, finasteride 5 mg daily, or both drugs for six months. Alfuzosin alone and alfuzosin-finasteride combination therapy significantly improved symptoms ...

Lancet Oncol 8: 21–25 Finasteride, a type 2 5α-reductase inhibitor, is used to treat benign prostatic hyperplasia (BPH) at 5 mg daily, and male-pattern alopecia at 1 mg daily. The 5 mg regimen ...

All participants received 5 mg/day finasteride and were randomly assigned to receive either counseling on the potential sexual adverse effects of the drug or no such counseling. Using patients ...